Use of SGLT2i in noHCM With HFpEF

This study is testing whether SGLT2 inhibitor medications (a class originally developed for diabetes that also benefits the heart) can improve exercise capacity and symptoms in people with non-obstructive hypertrophic cardiomyopathy (a type of thickened heart muscle that doesn't block blood flow) who also have heart failure with preserved ejection fraction. **You may be eligible if...** - You are 18 or older - You have been diagnosed with non-obstructive hypertrophic cardiomyopathy - Your heart pumping function is at least 50% - You have elevated heart stress markers in your blood - You have mild to severe heart failure symptoms (NYHA class II–IV) - You can complete a stress test with adequate effort **You may NOT be eligible if...** - You have had septal reduction therapy (a procedure to reduce the thickened heart muscle) in the last 3 months - You had an acute worsening of heart failure in the past 3 months - Your blood pressure is too low or your kidneys are not functioning well - You have a significant blockage of blood flow out of the heart at rest or with exertion - You are pregnant or planning to become pregnant Talk to your doctor to see if this trial is right for you.